242 related articles for article (PubMed ID: 27815980)
21.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
[TBL] [Abstract][Full Text] [Related]
23. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
24. Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells.
Shang X; Ding N; Xiang G
Eur J Med Chem; 2012 Feb; 48():305-12. PubMed ID: 22226547
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis and cell growth arrest in A375 human melanoma cells by diorganotin(IV) and triorganotin(IV) complexes of [meso-Tetra(4-sulfonatophenyl)porphine] manganese(III)chloride.
Costa MA; Zito F; Emma MR; Pellerito L; Fiore T; Pellerito C; Barbieri G
Int J Oncol; 2011 Mar; 38(3):693-700. PubMed ID: 21206968
[TBL] [Abstract][Full Text] [Related]
26. Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Singh P; Verma P; de Vos D
Invest New Drugs; 2010 Oct; 28(5):587-99. PubMed ID: 19641849
[TBL] [Abstract][Full Text] [Related]
27. Anti-cancer activity of di- and tri-organotin(IV) compounds with D-(+)-Galacturonic acid on human tumor cells.
Attanzio A; Ippolito M; Girasolo MA; Saiano F; Rotondo A; Rubino S; Mondello L; Capobianco ML; Sabatino P; Tesoriere L; Casella G
J Inorg Biochem; 2018 Nov; 188():102-112. PubMed ID: 29807841
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic Activity of Organotin(IV) Derivatives with Triazolopyrimidine Containing Exocyclic Oxygen Atoms.
Attanzio A; D'Agostino S; Busà R; Frazzitta A; Rubino S; Girasolo MA; Sabatino P; Tesoriere L
Molecules; 2020 Feb; 25(4):. PubMed ID: 32075253
[TBL] [Abstract][Full Text] [Related]
29. The in vitro antitumour profile of some 1,2-diaminocyclohexane organotin complexes.
Bonire JJ; Fricker SP
J Inorg Biochem; 2001 Jan; 83(2-3):217-21. PubMed ID: 11237262
[TBL] [Abstract][Full Text] [Related]
30. Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions.
Basu Baul TS; Dutta D; de Vos D; Höpfl H; Pooja ; Singh P
Curr Top Med Chem; 2012; 12(24):2810-26. PubMed ID: 23368104
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of fluorescent pyrrolyldipyrrinato Sn(IV) complexes.
Crawford SM; Al-Sheikh Ali A; Cameron TS; Thompson A
Inorg Chem; 2011 Sep; 50(17):8207-13. PubMed ID: 21786802
[TBL] [Abstract][Full Text] [Related]
32. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS
Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259
[TBL] [Abstract][Full Text] [Related]
33. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E
J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688
[TBL] [Abstract][Full Text] [Related]
34. Diorganotin(IV) derivatives of N-methyl p-fluorobenzo-hydroxamic acid: preparation, spectral characterization, X-ray diffraction studies and antitumor activity.
Naqeebullah ; Farina Y; Chan KM; Mun LK; Rajab NF; Ooi TC
Molecules; 2013 Jul; 18(7):8696-711. PubMed ID: 23881054
[TBL] [Abstract][Full Text] [Related]
35. The interaction between SBA-15 derivative loaded with Ph
Maksimović-Ivanić D; Bulatović M; Edeler D; Bensing C; Golić I; Korać A; Kaluđerović GN; Mijatović S
J Biol Inorg Chem; 2019 Mar; 24(2):223-234. PubMed ID: 30759278
[TBL] [Abstract][Full Text] [Related]
36. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization and crystal structure of organotin(IV) N-butyl-N-phenyldithiocarbamate compounds and their cytotoxicity in human leukemia cell lines.
Kamaludin NF; Awang N; Baba I; Hamid A; Meng CK
Pak J Biol Sci; 2013 Jan; 16(1):12-21. PubMed ID: 24199481
[TBL] [Abstract][Full Text] [Related]
38. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity.
Li Q; da Silva MF; Pombeiro AJ
Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, antimicrobial and antitumor screening of some diorganotin(IV) complexes of 2-[(9H-Purin-6-ylimino)]-phenol.
Rehman W; Badshah A; Khan S; Tuyet le TA
Eur J Med Chem; 2009 Oct; 44(10):3981-5. PubMed ID: 19464768
[TBL] [Abstract][Full Text] [Related]
40. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
